ARCHIVES

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994

Letter: No Intent To Link Flags With NSABP Inquiry, ORI’s Bivens Writes

March 10, 1995

NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants

September 29, 1978

Taxol Released On Compassionate Use Basis To Centers; Ohio, Columbia Begin Treatments

October 18, 1991

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006